GT

annoying12345

I cant read. Can you give me the coles notes? Specifically, coles notes on how GT used SUPER shares? Im scared though, sounds super ominous!

Few_Entertainer_5523

Should’ve gotten a GT3 RS. -Poor man giving rich man advice

Bromine_Bro35

Don’t be disheartened by a so-called ‘poverty mindset,’ a poverty mindset is like a hungry LION… it will NOT rest until it is satisfied (GT3RS)

Fun-Choices

I’ll go be fucking sad in my Porsche GT3

annoying12345

I actually held both in equal amounts but sold trul to buy more GT the last time trul ran $2/share more than GT. Hope what I just typed makes sense. Its been a long day. They were roughly even and trul ran harder so I purchased more GT with the Trul shares that I then, sold.

Ok-Replacement9595

Kinda surprised they didn't shove it down there in the last few minutes. Also, someone really bought up GT in the last minutes.

1098duc_w_the_termi

It depends what he’s looking for. A true drivers car vs a status symbol. Same price range. Having driven a McLaren 570s, an F8, huracan, and a few of the top of the line porches (including the GT3), I prefer the GT3. I daily an M8 and I would rather have that than the two he listed

SilviOnPC

a GT3 is nowhere near close to a 296 GTB, and this is coming from a huge Porsche fanboy.

tallyhoallaboard

Of course GT500

jtg6387

It basically made a GT4C Lusso without the hatch

Clackamas_river

This may be another $100+ day for MU. 310 deep ITM calls for march are printing so hard. GT3 or carrera-4-gts?

ASource3511

I wish EVs are just bland, they are aggressively offensively ugly. Look at the C class EV, the AMG GT 4 door and the iX3.

AutoModerator

Hello GT3RS40, Your comment has been removed because you have an unverified email. Please follow [This Tutorial](https://www.wikihow.tech/Verify-Email-on-Reddit) to learn how to verify your email. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*

boat_hamster

The Conti GT and Flying Spur only share their platform with the Porsche Panamera. And the two proper Lambos are unique to Lambo. It's only the SUVs that are parts bin specials.

oandakid718

Think about it this way, pick up 3 or 4 taycans and make your money back when your PPFed Sonderwunsch GT3RS arrives and every car dealer will be begging you with a blank check

oandakid718

Yea every luxury car brand does this nowadays. Audi etrons for the new RS5 allocation, Porsche Taycans for GT2/3 RS allocations (or any bespoke Porsche spec for that matter), and Ferrari will try to dump these to give new Ferrari owners a chance to grab future allocations (which are being currently manipulated by dealers on the market, a la the 812’s, 458’s, and now even 360’s are being manipulated too) Tesla also does this except elons allocating model x’s to Space X entities that cannot be cross referenced

Sailing_Mishap

An eTron GT RS is like 1/4 the price and actually looks great.

oandakid718

Ahh yes, the ole’ Porsche trick where they make you buy 3 Taycans for a GT3RS allocation

Chemical-Operation83

What did you lose 100k on? I lost a similar amount on Desktop Metal but I haven’t thought about it much until I saw your post, and it definitely wasn’t with money I was planning to put down on a house, it was more of a GT3 911 yolo that never materialized for me. Thanks a lot OP 😅

iSOBigD

Taycans are not in fact pretty sweet. They deprecoate worse than any Porsche, no one wants them compared to every other car they sell, and mostly people have to buy 5+ just to be allowed to purchase a GT3 RS and other cool Porsches so they depreciate like $40k in a day as people buy and sell them immediately. You can watch videos of people buying Porsches and having to waste hundreds of thousands on Taycans just to be allowed to buy the car they actually want at MSRP lol. They'll be worth nothing in 10 years.

vermilli21

My goal this year is make enough money to buy the GR GT when it comes out

Star_Lord924

Guys....we may actually get GT6 before we get a fucking deal done

perceptive_AI

Leon drove a Cayenne Turbo GT to farm aura. I want one so bad now but it's $215k (before taxes).

kyle_yes

Damn and market thinks GT is horrible with 18.2bil anual revenue and annual loss of 1.7bil

potato111a

Lambo too common, getting an AMG GT

Ragnar_Actual

GT53? Must be one of the poors

gavalo01

i used to when i was young and nimble, 2015-2021 ish, before the trails got kinda full of try hards, old dudes ripping it uphill on ebikes, and 7 year olds thatll shred harder than i ever will. I do take bike GT hardtail to work tho

AutoModerator

Hello GT3RS40, Your comment has been removed because you have an unverified email. Please follow [This Tutorial](https://www.wikihow.tech/Verify-Email-on-Reddit) to learn how to verify your email. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*

m0viestar

GoPro: reddit talked about it a month ago. Historically, stocks bumps when the algos pick it up as a discussion and then a few months later the bot posts hype it again to drive fomo.   Expecting a random 15-20% jump on no news.   Goodyear Tire(GT): Short position as they don't seem to be surviving much beyond end of the year.  Lots of their loans refinanced during covid to acquire Cooper have come due and they're borrowing more to pay them off.  It's pretty dire. 

AutoModerator

Hello GT3RS40, Your comment has been removed because you have an unverified email. Please follow [This Tutorial](https://www.wikihow.tech/Verify-Email-on-Reddit) to learn how to verify your email. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/Shortsqueeze) if you have any questions or concerns.*

Kindled808

New Chinese hypercar in GT7, pretty sweet

LocksmithGlass717

If anyone is expecting a quick response to the power supply I’d kinda hold off. It’s going to take literally years to get the plants built. Even a simple cycle GT takes a couple of years. Names like DUK , AEP , Dominion are all waiting on the turbine producers backlog. Transformers are another choke point.

Floorgasm

Because you can ape it and get like 5 GT3 RS'

Apple2o

Driving this 2025 mustang GT with paddle shifters is a dream The rev matched downshifts are soooo good

guzzledglizzy

Money may not buy you happiness, but it can buy you a GT-R and a Midwest cosplay baddie and that’s all I fuckin want

StarMaker7

Do you really think GT will 10x? I also believe that this stock could rally even higher and possibly stabilize there... I'm I dreamin

Metal-Water

Fuck guys. I’m haunted by the thought of a Porsche 911 GT3 RS in my driveway.

Apple2o

Haven’t even made it to 4500 miles in this new mustang GT and I already blew a speaker out 😤

OorvanVanGogh

Trul has greater exposure to medical. If medical rescheduling holds, but rec does not materialize, GT will pay full 280e tax, Trul will not, as it's heavily into FL med.

alfred250

SICK! I am a car person! All i ask is a Eleanor GT500 gone in 60 edition, a 1960 Bronco, and a low key ferris bueller 1961 250 California

grant1057

Yikes, you lost a 911 GT3 today

YOLOdollhair

I wish you could see where your money went. Is it just sitting in some market makers account? Did it get used to buy a GT3 or a luxury vacation in Bali? Maybe it bought Ken Griffin's toilet paper for the year?

Correct_Proposal_409

Hey-- I'm waiting. For me, nothing has changed on the science and the potential, so there's nothing to do but buy, sell, or hold. I already have a very large position, otherwise I'd be adding on the dips. The only other consideration is whether you think there is an opportunity cost of holding. I keep going back to this: there is no other drug that has shown the ability to reduce GluSph to the extent or reliability that GT-02287 has shown. This is a primary role of Gcase, and 2287 is designed to make Gcase function effectively, so mission accomplished there. There are a large number of PD patients, GBA1 and idiopathic who have elevated levels of this toxic lipid. And outside of PD, there are patients with DLB and Gaucher's who also have elevated levels. Even as a therapy that is part of a broader approach to one or more of these diseases, being able to reduce GluSph is very valuable-- or at least will be at some point. I do believe that the extension patients who had elevated levels of GluSph will continue to show durability and separation as compared to the patients who were not elevated at baseline. And if all patients continue to show durability, that's even better. Phase 2 funding remains a question, but I believe the company has a plan and know what they are holding.

HowLongCanIMakeACock

I bought a GT3 instead

Euler007

Shitty? Nearing 80k in my P2 and every day starts great because I get to drive it. Model 3 feels like a go cart compared to it. The 4 looks fantastic and has a ton of space inside, the 3 is the American Polestar, the 5 will be a fantastic GT while the S isn't even in production, the 6 will beat the Roadster to market, the 7 will be the big banker car and the refreshed 2 will fix the compromises that went into their first full EV. The 1 is a rare collectors piece.

paeschli

I don't remember people on the Contrarian Invesyor forum arguing that Apple would buy the company. It was rather that Apple would switch from using Corning ion-strengthened glass to GT Advanced Technologies sapphire glass for the next iPhone. Easy to make fun of the echo chamber investing philosophy but even tech 'journamists' like MKBHD were onto it by releasing a video showcasing a sapphire screen "from Apple's assembly line".

mm1029

Can confirm, 131 GT score and I went infantry in the Marine Corps

AxeEm_JD

Highly regarded individual here.  135 GT, ended up a 68W in 2009 with zero recruitment incentives.

Blkpwrlftr2

Thankfully I still live at home and my only expenses are a $380 a month car payment and a $150 student loan payment. I had a $500 a month mustang GT but someone offered to pay it off and hand me 2k in cash so I bought an older cheaper car that’s better on gas, I save double the money in gas almost, insurance dropped by $600ish every year and carpayment dropped by $120 a month. So my car really was the only thing I splurged on but I got rid of it too for more investments/savings😅.

cnhonker

Impressive. Do you have the money to buy a Porsche GT3 RS?

Ok-Bullfrog-2243

Look at WCU and GT Ressrouces (GT) too

CMTTrader

You could have bought one of the following: 2026 Corvette Z06 2LZ 2026 Range Rover 2026 Lexus LC 500 2026 Lexus LX 700 2026 BMW X7 M60i 2026 BMW M5 2026 BMW M850i 2026 Lotus Emira 2026 Mercedes S 500 2026 Mercedes AMG GT 2026 Audi SQ8 2026 Cadillac Escalade ESV Instead, you bought SNAP 🤣🤣🤣

Correct_Proposal_409

Temporary pain and completely unjustified. No good reason. The only explanation IMO is that it phase 2 funding is still unknown. But with reduction in GluSph, and reduction in DDC, along with clinical improvement in that same group, they are showing something that no drug or therapy has shown before. A couple links you might be interested in. One is a [recent article] on GT-02287, and the other is on [biomarker DDC](https://www.drugdiscoverynews.com/new-spinal-fluid-biomarker-distinguishes-parkinson-s-and-lewy-body-dementia-from-alzheimer-s-disease-17091) which is emerging as one of the most important biomarkers in neurodegenerative disease.

torokunai

yeah I don't understand what's so hard about creating another 300ZX, 3000GT VR4, FD RX-7 etc.

EntrepreneurOld7858

Over a Ford? Sure! Real talk my K5 GT slaps. I absolutely love it.

2Loves2loves

it is worth what someone is willing to pay you. Like I said, look at the hot rod market. The guys that fought in Korea wanted those cars, but now they are old and dying, and they just aren't wanted buy the next generation. That is the gamble. will someone want a GT3RS in 25 years? probably. will they pay more than the stock market appreciated? (7%/yr on average). I've owned 911's they have caught fire in the last 10 years. but trees don't grow to the sun... You want a toy, fine, but don't call it an investment. IMO, it's a gamble.

Fragrant-Key5115

Hard to argue with that as a philosophy but that’s where my research has led to me posing this question in the Reddit post. Some Porsche 911’s are literally made to be track cars first, road cars second. Some of the GT3 RS’ have appreciated by 30 to 40% over a relatively short time frame and most dealers and buyers/investors understand that they have likely been booted around a track for hours but still the prices increase!

Ok-Bullfrog-2243

forgot : GT Ressources (GT) and World Copper (WCU)

Detailed23

Ferrari's, Lambos and GT Porsches.

Awkward_Resolve_9511

Did my mixed game/repeated game course back in 2017, from one of the absolute best in the business. Dude’s main trade is corporate finance, GT was only his side hustle. I still review those course materials once in a while.

windstride3

Honestly, from what I can tell - nothing. The company CMO presented at a conference in Copenhagen on "safety, tolerability, biomarkers, and clinical scores from the completed Part 1 of the study support continued development of GT-02287 for PD. Of the 19 participants who completed dosing in Part 1, 16 chose to continue in the ongoing nine-month extension (Part 2), further supporting the tolerability of GT-02287. A Data Monitoring Committee meeting on March 5, 2026, concluded that the study should continue without any changes."

PostingToPassTime

Might I suggest adding AMC, TSLA, DJT, NMAX, & GT? These are from my LOL watch list.

Apple2o

The loaded mustang convertible GT is getting a plate called “OKLOPAY” It’s still surreal to be up like 20 years of work, taking a piss and making peoples annual salaries. Sort of, now it’s just normal

Correct_Proposal_409

From today's press release. Companies are very careful about using "disease-modifying" in their press-releases, especially in the context of the following sentence. The data fully justifies this statement IMO, and if anything, they are still being conservative with their wording: “The data from our Phase 1b study furthers our hypothesis that GT-02287 is among the first disease-modifying therapies promising to shift the treatment paradigm in PD from symptom relief to halting or slowing symptom progression, targeting the causative biology (or pathophysiology) of PD to enable a more durable and predictable treatment effect for those living with PD.”

Master-Vanilla-5625

Biotech often follows a pattern of build up (hype) in anticipation of news dropping where people buy in the hopes of it taking off. When the news does not result in an influx of buyers, loads of people tend to take there losses, and go looking for a new candidate that may take off short term. There is really no telling beforehand if the news is going to cause the stock to rocket or dump. With biotech you always have to make the decision on whether you are happy with the profit you have now, or believe that long term there will be a moment the stock could rise significantly. If you go for the long term option, you have to accept and ride through the volatility that is innate to this sector. Personally I bought at a low price and also think the stock has a decent chance of going to a much higher price than it is at now. So I will hold through the news, regardless of whether it goes up or down, as I believe that sometime in the future (could be next week, could also very well be months away) GT-02287 has the potential to attract a big partnership/buyout for Gain.

Possible_Cheek_4114

MOBX 

drew-gen-x

I made a small bet on 100 shares of $GT. Goodyear is a crap company but they are being heavily shorted due to the spike in crude oil prices. Crude oil is the most expensive input into tires. I really don't like shorting but if I think crude oil is going down I will buy some of the shorted stocks as a trade, not hold.

Independent-Tree-985

>> Game and Commercial Fish: Kingfish, Tuna, Barracuda, Giant Trevally (GT), Queen Coris, and Grouper. Common/Local Species: Sea Mullet (Ifi), Goatfish, Threadfin, and various Snappers. >> Reef and Coastal Fish: Zebra lionfish, Blacktail angelfish, Long-spine porcupinefish, and Spotted-fin porcupinefish. Pelagic Species: Various species of mackerel, sardines, and anchovies. >> Other Marine Life: The area is also known for dolphins, various species of sharks (such as hammerheads), and coral reefs

Yogurt_Up_My_Nose

lol gayest humble brag. just say. I bought a mustang GT and it needs premium, oops I fucked up.

Appropriate-Ask-9862

There’s a lot of excitement around GT-02287, but people should understand what the drug is actually trying to do. It’s not a cure and it doesn’t rebuild dopamine pathways. The mechanism targets lysosomal dysfunction by stabilizing the enzyme glucocerebrosidase (GCase). The idea is that better lysosomal function helps cells clear alpha-synuclein and reduces stress on dopamine neurons. In other words, the goal is to slow the process that eventually kills those neurons. The problem is that Parkinson’s symptoms usually appear after a large portion of dopamine neurons in the substantia nigra are already gone. Once those neurons are dead, the brain doesn’t regenerate them in meaningful numbers. So drugs like this are more about protecting the neurons that are still alive rather than restoring what’s already been lost. That means the biggest potential benefit would likely be in very early disease or even in people who are at high risk but not yet symptomatic, like certain GBA mutation carriers. For someone with advanced Parkinson’s where much of the degeneration has already occurred, a therapy like this probably isn’t going to dramatically change symptoms. At best it could slow further decline. Still important research, but it’s better thought of as a disease-modifying strategy rather than a miracle drug.

Keeg117

The best way to look at why GT-02287 is different from the long list of failed Parkinson’s drugs is to look at the "Pipe vs. Puddle" analogy. 1. For twenty years, big pharma has been trying to mop up the "puddles"—specifically a protein called alpha-synuclein that clumps together in the brain. Drugs like Biogen’s Cinpanemab failed because by the time you’re cleaning up those clumps, the brain cells are already dying. You’re treating the symptom, not the cause. GT-02287 fixes the burst pipe. It goes "upstream" to fix a specific enzyme called GCase. When this enzyme is broken, the brain can’t clear out waste, and that’s what causes the "puddle" in the first place. By acting as a chaperone to fold that enzyme correctly, Gain is helping the brain fix its own trash disposal system. 2. In the past, we tried using large antibodies to fix Parkinson's, but they have a massive "Brain Barrier" problem. They are just too big to get into the brain in high enough concentrations to matter. GT-02287 is a small molecule. It’s designed to be taken as a pill and easily cross into the brain. Because it restores the enzyme's shape, it doesn't just do one thing—it triggers a "cellular rescue" that helps the cell's power plants (mitochondria) start working again and stops the cell from essentially "giving up" and dying. 3. We aren’t just looking at mice anymore; we have human data from the Phase 1b trial that is pretty stunning for this field: The toxin drop: In patients with high levels of toxic waste (GluSph), the drug cut those levels by 81% in just 90 days. That is the "smoking gun" that the drug is doing exactly what it was designed to do. The physicsl bounce back: These same patients saw a 6.17-point improvement in their motor scores. Usually, Parkinson’s patients just get worse every year. Seeing a 6-point improvement in three months is a massive signal that the drug is providing a real-world functional benefit. The neuron health test: The next big milestone is the DDC biomarker data coming on March 17-18. DDC tracks how well your dopamine-producing neurons are functioning. If that data is positive, it’s basically proof that we aren't just masking symptoms—we're actually saving brain cells. By fixing the pipe instead of just mopping up the puddle, Gain is tackling the disease in a way that hasn't been done successfully before.

Correct_Proposal_409

Gain CEO: “Rather than simply trying to boost enzyme activity in the lysosome, GT-02287 stabilizes GCase folding and trafficking throughout the cell, restoring function across multiple compartments, including those critical to mitochondrial health. That matters because Parkinson’s can be seen as a disease of cellular stress, impaired waste clearance, and energy failure.”

microcapreturns

Here are the research reports. Gain Therapeutics(GANX):  KOL Reports : GT-02287 Shows Signs of Disease Modification https://gaintherapeutics.wordpress.com/2026/01/14/gain-therapeuticsganx-kol-rpeorts-gt-02287-shows-signs-of-disease-modification/ 

moorhound

No, because we've been letting the defense industry suck on an unlimited budget titty for 60+ years and all of our weapons systems are price-inflated to the stratosphere. Our shits good, but hot damn does it cost a lot of money. It's like a destruction derby where they're using 200,000 mile Kias and we're using 2026 911 GT3s.

ChamberofSarcasm

I can't believe we got another war before GT6

microcapreturns

GT-02287 is actually correcting the problem and will show data at AD/PD on how they repair dieing neurons. That's incredible news.

Correct_Proposal_409

The DDC biomarker is exciting. And DLB has a big overlap with Parkinson's pathology, so very relevant. BTW, DLB is a giant untapped market for disease-modification. GT-02287 might even more consistently fit a higher number of cases there than in Parkinson's.

microcapreturns

Just read another published article yesterday showing DDC is an accurate biomarker for both PD and Lewy Body. Gains GT-02287 acts at the beginning of the problem and repairs neurons and reverses Parkinsons. Everybody else's drug works downstream and won't impact the DDC biomarker. It stands alone.

Correct_Proposal_409

You can use your own rhetorical "many trials have failed and therefore this is destined for failure" for any therapy being developed. Historical failure rates raise the bar, but they don't determine the outcome of a mechanistically unique therapy with a demonstrated CNS pathway correction. Here we have a genetically validated pathway (GBA1), plus strong evidence of Gcase dysfunction and corresponding lysosomal lipid accumulation in a good portion of idiopathic cases. If you are an MD, you should understand the relevance of GBA1 PD and Gaucher's-- they share the same GBA1 mutation. Life-saving, disease-modification was achieved by addressing dysfunctional Gcase, with GluSph being the most important biomarker for confirmation of target-engagement and disease progression. Of course, these Gaucher's therapies do not cross the blood-brain barrier. GT-02287 addresses dysfunctional Gcase in the brain. The reasonable take would be, "let's see how reducing GluSph levels translates to reduction in downstream biomarkers and in clinical symptoms in Parkinson's cases over a longer timeframe." Not, "I'll eat my shoes if this works". Hard to take you seriously when you are so seemingly dismissive without offering mechanistic reasoning to back up your statements. It almost seems as if you want it to fail. Do you work for a competitor of Gain? That would explain it. "Your post history is rabid with support of this stock... you are looking for someone to buy your bags." This is an immature, ad hominem assumption that does not address the science. Yes, I believe strongly in this treatment. I think it is the most promising PD treatment being developed, for the reasons I've detailed in my many posts. I'm lucky to have a very low basis. I *am* looking for BP to buy my shares for multiples above by basis. Not retail investors. I won't convince you-- not trying to convince you. But readers should understand that your baseless dismissal has no bearing on what many experts think is a very promising development in Parkinson's disease treatment. Maybe we should follow-up in September and see how durable the data is with the 16 out of 19 patients who elected to continue with the treatment despite the tests and additional lumbar puncture, many of whom have reported improvements, along with their clinicians. Beyond UPDRS, some of these reports may be anecdotal, but if they truly have regained sense of smell, this does not happen with placebo.

stocktadercryptobro

Wen Eleanor GT500?

one

The thesis is coherent, the sizing is... committed. The Supreme Court catalyst is a legitimate wildcard that most aren't pricing. **The GT3RS scenario:** NVDA needs to hit roughly $210-220 by 3/20 for this to be life-changing money. That's a 15-20% move in 5 weeks. Aggressive, but: * Earnings beat + raised guidance to $70B+ * SCOTUS strikes down IEEPA tariffs same week * Algos pile in, short covering accelerates It's not impossible. It's just needs everything to hit. **The Wendy's scenario:** Stock flat-to-down post earnings, calls expire worthless or near it, you're sitting on shares underwater and short puts getting tested. Your main risk is timing/structure: concentrated short-dated calls + earnings vol crush + binary SCOTUS timing. If you're genuinely comfortable with the downside, respect. If not, you could always convert some of your long calls into vertical spreads to reduce risk and theta decay. But GT3RS requires moon mission and spreads won't get you there. Godspeed.

CEOofBeanz

Mustang GT is inferior to German sports cars, I’ll still buy to support the factory and engineers

Correct_Proposal_409

Correct. And I think it is safe to say that David Einhorn is aware of what is going on with Gain and GT-02287. Michael J Fox Foundation is definitely aware. Listen to Gene Mack speak at the Sach's Forum on January 11th, mentioning how MJFF has been a great resource to them. Also not that Gene is sitting right next to Gaia Skibinski, Director of Discovery and Translation at MJFF. (Start at around 52 minutes): [https://www.youtube.com/watch?v=Hvsllm583Vc](https://www.youtube.com/watch?v=Hvsllm583Vc)

Correct_Proposal_409

Nothing has changed fundamentally about the science and the data except that it has gotten better. I'm as disappointed in the share price as anyone, but the potential is giant here. The data from the extension will keep coming in, and by the sound of company statements, it is very positive. If you want more info, there is active discussion over at Stocktwits. I've been adding as the price has fallen, and I've never owned more than I have now. I still believe strongly that GT-02287 is the most promising disease-modifying therapy being developed.

tedontwo

I found the Select and Premium to be a little bouncy, the GT is firm but more planted. Horses for courses, glad you like yours!

tedontwo

I really prefer the MagnaRide suspension and big brakes on the GT. The ride is firm but I found the lower trims a little bouncy. Plus it's a big girl, the big brakes are handy for spirited driving. If it's a daily that never sees performance driving I'd agree, the Selects and Premiums are pretty solid.

tedontwo

The original comment was in reference to a Mach-E 👍 they come in a GT trim.

Amaeyth

Sorry I should've clarified, I meant a 2015-2020 GT350. But yes the new ones are also absurdly marked up when dealers do special order them from Shelby American. Ive seen ADMs on RTRs and Shelby American variants in excess of $30k. I was on a lot last year remarking on one in mystichrome saying plainly, 'thats a nice car, but Im absolutely not paying 150k for that'. The sales rep said 'for this one you would'. My response was a simple, 'no way this is still a Mustang.'

nomaam05

GT owner here, I wouldn't bother with the GT unless you can't find a Premium for less.

Patient_Commentary

We got a premium. We test drove the GT and didn’t like that the suspension was tighter. It was just so bumper. But other than that, they are all amazing! Similar to the other guy, best car I’ve ever owned.

sinovesting

You must be thinking of the GT500. GT350s are no longer sold new but they can be had in good condition for sub $50k easily.

notevenapro

In 2006 my wife and bought two brand new GT's, 27k each, 0% financing.

ShallWeGiveItAFix

I feel bad it’s failing but I snagged a Mach E GT motor for next to nothing. The thing is major!!!

RaggaDruida

And about enthusiast cars, they only make the mustang. They had some history, iconic vehicles like the Escort RS Cosworth, Capri, GT, etc but as far as I know they don't make anything similar any more. Add to that the shrinking market and the negative image that usa products have outside of their own national market...

CelebrationNo5541

That Coyote engine is no joke. Just got a new base GT Mustang simply because of the engine and its ability to take a beating on a race track.  Last Coyote I had was a drag car and you are spot on with the boost. I ran it with stock oil pump gears at 1khp to the ground for over a year before it blew up. 

The_Zenki

Ignorant to them, didnt know if GT meant about gas coupes or the machE, but now I know MachE can get GT badging/trim

tedontwo

The key part is that it really is only a few extra hundred to go from a base model Select to a loaded GT. The value is unmatched at the moment. Although they can be said for a lot of EVs at the moment if a different model fits your needs better.

The_Zenki

Mach E GT?

fasurf

Awesome to hear. GT is worth the extra couple of bucks? Can find one under 30.

tedontwo

I bought a used GT with 38k on it for $29k and it's the best car I've ever owned.